繁中
Home／News & Events／Latest News

Latest News

2026-07-09

Strategic Planning for TPEx OTC Mainboard Listing Application

Read More
2026-05-21

Miaoli New Plant Groundbreaking & 100% Acquisition of Leeman Biotech

Read More
2026-03-30

18F-FBPA Approved for Clinical Trials by TFDA/MOHW

Read More
2025-09-24

Resolution to Withdraw Taiwan Innovation Board (TIB) Application and Shift Strategic Focus to TPEx Mainboard Listing

Read More
2025-07-19

Our company completed the share transfer on July 1, 2025, acquiring 80% equity.

Read More
2025-03-31

Our company signed an accelerator procurement contract with IBA on March 28, 2025.

Read More
2025-03-28

Our company signed the Lehman Shares Transaction Agreement on March 28, 2025.

Read More
2024-07-17

Our company was approved as a publicly traded company by the OTC Exchange on July 17, 2014, and obtained the qualification to be listed on the Emerging Stock Market on the same day (stock code: 7762). Trading on the OTC market began on July 25, 2014.

Read More
2024-07-02

On July 23, 2013, PPhB held a successful pre-opening briefing session for institutional investors on July 23 2024 in the Grand Hyatt Hotel.

Read More